Risk factors and current state of therapy for anemia after kidney transplantation

Yan Tang; Jiayu Guo; Jiangqiao Zhou; Zijie Wan; Jinke Li; Tao Qiu

doi:10.3389/fmed.2023.1170100

Risk factors and current state of therapy for anemia after kidney transplantation

Front Med (Lausanne). 2024 Jan 8:10:1170100. doi: 10.3389/fmed.2023.1170100. eCollection 2023.

Authors

Yan Tang^#^{1

2}, Jiayu Guo^#^{1

2}, Jiangqiao Zhou^{1

2}, Zijie Wan^{1

2}, Jinke Li^{1

2}, Tao Qiu^{1

2}

Affiliations

¹ The Department of Organ Transplantation, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
² Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.

^# Contributed equally.

Abstract

Post-transplant anemia is one of the most common complications in kidney transplant recipients, severely affecting patient prognosis and quality of life, and is an independent predictor of graft kidney loss and patient mortality. However, our clinical understanding and the attention given to post-transplant anemia are currently insufficient. This paper reviews the current status, risk factors, and therapeutic progress in anemia after transplantation in kidney transplant recipients. We recommend that clinical staff pay attention to anemia and its complications in kidney transplant recipients and intervene early for anemia.

Keywords: anemia after transplantation; intervention; kidney transplantation; research progress; risk factors.

Publication types

Review

Grants and funding

This project is supported by the National Natural Science Foundation of China (Nos. 81870067 and 82170664, JZ) and Wuhan Science and Technology Bureau (No. 2020020601012213, JZ).